| Authors: |
Henriksen T; Movement Disorder Clinic, Department of Neurology, University Hospital of Bispebjerg, Bispebjerg Bakke 23, 2400 NV, Copenhagen, Denmark. Tove.Henriksen@regionh.dk., Martínez-Castrillo JC; Movement Disorders Unit, Ramón y Cajal University Hospital, IRYCIS, Madrid, Spain., Huisman MHB; Department of Neurology, St. Antonius Hospital, Hospital Utrecht, Utrecht, The Netherlands., Dhanani S; Banner Sun Health Research Institute, Sun City, AZ, USA., Peckham E; Central Texas Neurology Consultants, Round Rock, TX, USA., Aldred J; Selkirk Neurology, Spokane, WA, USA.; Inland Northwest Research, Spokane, WA, USA., Bergmann L; AbbVie Inc., North Chicago, IL, USA., Shah MB; AbbVie Inc., North Chicago, IL, USA., Gupta R; AbbVie Inc., North Chicago, IL, USA., Kukreja P; AbbVie Inc., North Chicago, IL, USA., Parra JC; AbbVie Inc., North Chicago, IL, USA., Fung VSC; Movement Disorders Unit, Westmead Hospital, Westmead, NSW, Australia.; Sydney Medical School, University of Sydney, Sydney, NSW, Australia. |
